|Bid||72.73 x 1800|
|Ask||72.73 x 1100|
|Day's Range||72.50 - 72.95|
|52 Week Range||20.10 - 300.00|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 18, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||117.20|
were up 0.7% ahead of the company's fourth-quarter earnings release after the closing bell Monday. Tilray is expected to more than double revenue in the first quarter 2019 from the fourth quarter 2018. For fiscal 2019, Tilray is expected to increase revenue 350% from fiscal 2018.
Cannabis stocks were higher Monday, as investors reacted to the latest tie-ups in the sector and awaited the release of quarterly earnings from Tilray Inc. after the close.
The Dow Jones industrials reversed from early losses to turn higher despite Boeing's renewed sell-off. Edwards Lifesciences stock jumped 8%.
Three months since passage of the Agriculture Improvement Act of 2018 (2018 Farm Bill), companies looking to expand their footprint in the industry have started diving into the federally legal U.S. hemp market through start-ups or mergers and acquisitions (M&A). Most recently, Canada’s second-largest cannabis producer, Tilray, Inc. (NASDAQ: TLRY), last month furthered its growth strategy by acquiring Manitoba Harvest, the world’s largest hemp foods manufacturer. It bought the Winnipeg, Canada-based company from Compass Group Diversified Holdings (NYSE: CODI) and other shareholders of Manitoba Harvest, for CAD $419 million (USD $317 million) in cash and Tilray stock, plus up to an additional CAD $49 million (USD $37 million) in Tilray shares after Manitoba Harvest hits certain 2019 benchmark incentives.
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at how the craft beer industry and the CBD sector are joining forces to bring CBD infused beer to consumers. New Frontier Data estimates that overall domestic cannabis sales grew 6.7% in 2018, while alcohol sales grew at 5% year over year (source:bw166). Craft beer and cannabis seem to be moving forward hand-in-hand as more and more cannabis companies look for partnership agreements with public or private brewers to bring CBD-infused beers to market.
-The illicit cannabis industry is estimated at $50 billion yearly, much of which will move out of the shadows and become a legal market in the coming years. One research firm estimates the legal trade could be worth $21 billion by 2021. - Item 9 Labs (INLB) could be one of these as they finish a major expansion project on their Arizona cannabis cultivation and production facility, doubling capacity.
Dow Jones futures: Apple and Microsoft are fueling the current stock market rally. But Boeing fell as the Transportation Department probes the FAA over its approval of the 737 Max.
With Tilray Inc.’s fourth-quarter earnings on the horizon, investors will at long last understand how much legal marijuana Tilray can actually sell.
Numbers By Barron’s is a two-minute financial podcast with three vital numbers to start your morning. Unlike most countries, China’s local authorities are in charge of producing economic statistics.
A look ahead for the week of March 16 including the FOMC meeting, and earnings reports from Tilray, FedEx and Micron Technology.
Now obviously this is a growth company in a growth industry, but $72 a share seems a bit excessive considering the plethora of competitors, and lack of profits. Indeed, the upcoming earnings release will need to prove that Tilray can create revenue growth big enough to convince the markets that its earnings could someday justify this very expensive stock. This quarter is a heavy test for Tilray because of the stock pricing.
Phil Denning and Dan McDermott of ICR The disgrace of Purdue Pharma after allegedly pushing OxyContin on doctors is a lesson for fast-growing cannabis companies as they develop environmental, social, and governance standards. That’s according to a new paper published by Phil Denning and Dan McDermott of the Special Situations Group at communications and advisory […]
HEXO's Revenues Rose Over 1,000% in Second Quarter(Continued from Prior Part)HEXO’s balance sheet In the second quarter, HEXO (HEXO) had total assets of 446 million Canadian dollars, which increased year-over-year from 334 million Canadian dollars.
Even if Tilray reports the kind of quarterly sales figures that Wall Street expects, the marijuana company’s stock will be trading at a whopping 100-times annualized revenue.
Northern Michigan University offers a four-year degree dedicated to medicinal plant chemistry, tied to the rise in legalized marijuana.
HEXO's Revenues Rose Over 1,000% in Second Quarter(Continued from Prior Part)Profitability In the earlier part of this series, we discussed how HEXO (HEXO) experienced solid growth in revenue in its second quarter. The company reported a gross income
Beto O'Rourke Supports US Marijuana LegalizationSupport for legalization This week, Beto O’Rourke announced his bid to run in the 2020 presidential race. While addressing an audience in Iowa, he called for the legalization of marijuana in the
as the revenue projections for the company begin to ramp at ever steeper levels as the market for its product matures internationally. The company is scheduled to report fourth-quarter results after the closing bell on Monday, March 18, and the expectations are for the company to report a 58% sequential jump in revenue. Tilray is expected to more than double revenue in the first quarter 2019 from the fourth quarter 2018.
A new study says marijuana is the fastest growing labor market in the U.S. Yahoo Finance's Zack Guzman & Jeanie Ahn, along with 'Afford Anything' Podcast Host Paula Pant discuss with Acreage Holdings CEO Kevin Murphy.
Colleges across America are now adding cannabis to their curriculum. Brandon Canfield, a chemistry professor at Northern Michigan University in Marquette, joins The Final Round to discuss how he got the idea for a major in medicinal plant chemistry.